Would you treat the prostate alone, or prostate and mets in an oligometastatic prostate cancer patient?

Answer from: Radiation Oncologist at Community Practice

It's a good question and we are tempted to answer "prostate and mets" as the literature is building up, but we are still waiting for randomized phase III trials. The evidence so far suggests that stereotactic ablative radiotherapy (SABR) is promising. SABR-COMET trial has shown an improved OS for SA...

Comments

Radiation Oncologist at Lake Huron Medical Center
Fantastic review of the literature! Thank you!

Radiation Oncologist at Rabin Medical Center
Agree, nice summary! You also communicate an appro...

Radiation Oncologist at START Center for Cancer Care
Would anyone do SBRT to the prostate in the settin...

Radiation Oncologist at Texas Oncology-Arlington Cancer Center North
When treating the primary per STAMPEDE what dose d...

Radiation Oncologist at Universite de Montreal
We use STAMPEDE doses or the equivalent. SBRT 35 G...

Answer from: Radiation Oncologist at Academic Institution

Enrolling in a clinical trial evaluating this clinical scenario is the best option.Off-protocol, I would likely offer radiation to the prostate (most likely 55/20 as per STAMPEDE, although a motivated patient who wanted definitive dosing would be not unreasonable) and SBRT the met(s) (a la ORIOLE, S...

Please select the option that best describes you:

Would you treat the prostate alone, or prostate and mets in an oligometastatic prostate cancer patient?

Related Questions